Visiongain Publishes Hemostats and Sealants Market Report 2021-2031

29 October 2020
Pharma

Visiongain has published a new report on Hemostats and Sealants Market Report : Forecasts by Product (Topical Haemostat, Adhesives & Tissue Sealant). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Global Hemostats and Sealants market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031. Growth in elderly population and occurrence of chronic conditions is one of the factors rendering drivers. Rise in the demand supported by growing number of surgical processes, is also driving the market growth during the forecast period.

COVID-19 Impact on Hemostats and Sealants Market
The COViD-19 has many industries globally. Some of the industries are growing which includes healthcare, pharmaceuticals, and emergency medical services. All these industries are positively impacted towards the growth owing to the spread of uncontrollable pandemic of COViD-19. The Hemostats and Sealants market is directly allied to the medical services which is in-turn is paved towards the growth due to the requirement of haemostatic and sealant tools for the geriatric population.

Market Drivers
Rise in the occurrences of chronic conditions of elderly population has boosted the growth of the Hemostats and Sealants market, globally. According to the Centres for Disease Control and Prevention (CDC) statistics, over 45% of American population suffers from at least one chronic condition needing critical care. Thus, these factors are impacting the market towards a positive growth.

Increase in the number of surgical procedures, nowadays have in-turn boosted the demand for Hemostats and Sealants products, globally during the forecast period.

Market Opportunities
Global Hemostats and Sealants market has given rise to a convenience of more treatment options for medical professionals. The modernized medical & surgical tools and developed technologies in the healthcare segment is enabling numerous opportunities for the Hemostats and Sealants Market towards growth.

Competitive Landscape
Major players in the Hemostats and Sealants marketinclude CryoLife, C. R. Bard, B. Braun, and Advance Medical Solutions Group, Pfizer among others.

Pfizer is expected to gain share on the owing to its acquisition of King Pharmaceuticals, which has been a major contributor to the market. Calculated trends expected to be followed by the players include collaborations with hospitals and care centres, R&D in the field of formulation development, incorporation of bacteriostatic properties, and aggressive marketing plans for natural adhesives, especially fibrin sealants.

Companies are also involved in mergers and acquisitions intended at ensuring sustainability and expanding geographicalexistence. For instance, in January 2015; B. Braun signed a contract with Cohera Medical Inc. for the distribution of TissuGlu in Germany, Portugal, and Spain. B. Braun is anticipated to endorse the product through its various commercial channels in all the three regions of Europe.

Companies such as Advanced Medical Solutions Group plc own direct sales force team in Germany, U.K., and Russia to effectively market the products in Europe. Companies are now introducing cost effective Hemostasis and tissue sealing agents to expand their customer base and this expected to contribute to the rising demand from emerging countries.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

Read

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

Read

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

Read

Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031

The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.

22 February 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever